InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Mayo Stephen, Directeur. Officer active across 1 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 3 filings have been published. The latest transaction was disclosed on 7 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
02,953 shares0
Common Stock
SEC:0001209191-22-017713:0·
04,292 shares0
Common Stock
SEC:0001209191-21-065315·
04,292 shares0
Common Stock
SEC:0001209191-21-065315:0·
3 of 3 declarations
About Mayo Stephen
Stephen Mayo is a Director at Sarepta Therapeutics, Inc. In this role, he participates in the governance of the company and in strategic decision-making. His expertise in the biopharmaceutical sector allows him to make significant contributions to discussions on innovation and the development of new treatments. He is also involved in various committees within the organization.
